Marshall Wace, LLP Pfizer Inc Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Pfizer Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 7,759,490 shares of PFE stock, worth $204 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

7,759,490

Previous 14,730,207 47.32%

Holding current value

$204 Million

Previous $426 Million 51.71%

% of portfolio

0.26%

Previous 0.55%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$24.8 - $30.19 $173 Million - $210 Million	-6,970,717 Reduced 47.32%	7,759,490 $206 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $259 Million - $294 Million	9,352,034 Added 173.89%	14,730,207 $426 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $136 Million - $159 Million	5,378,173 New	5,378,173 $150 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $43.8 Million - $56.9 Million	-1,676,211 Reduced 69.57%	733,287 $21.1 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $64.7 Million - $75.7 Million	2,017,709 Added 515.0%	2,409,498 $79.9 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $12 Million - $13.8 Million	331,231 Added 546.96%	391,789 $14.4 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $24.4 Million - $31.7 Million	-619,116 Reduced 91.09%	60,558 $2.47 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $140 Million - $183 Million	-3,351,413 Reduced 83.14%	679,674 $34.8 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $95 Million - $116 Million	-2,172,001 Reduced 35.01%	4,031,087 $176 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $178 Million - $212 Million	3,836,099 Added 162.07%	6,203,088 $325 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $135 Million - $168 Million	-2,960,742 Reduced 55.57%	2,366,989 $123 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $156 Million - $231 Million	3,778,140 Added 243.82%	5,327,731 $315 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $59.3 Million - $76.2 Million	1,510,477 Added 3861.73%	1,549,591 $66.6 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $28.4 Million - $32.2 Million	-791,097 Reduced 95.29%	39,114 $1.53 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $27.8 Million - $31.4 Million	830,211 New	830,211 $30.1 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $13.6 Million - $16.4 Million	-450,046 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $74.3 Million - $106 Million	-2,746,985 Reduced 85.92%	450,046 $14.7 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $63.9 Million - $72.5 Million	1,940,246 Added 154.38%	3,197,031 $125 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $40.8 Million - $52.9 Million	1,256,785 New	1,256,785 $45.2 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $24.2 Million - $27.2 Million	-655,261 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $1.71 Million - $1.88 Million	-45,570 Reduced 6.5%	655,261 $27.8 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $25.1 Million - $28.6 Million	652,622 Added 1353.73%	700,831 $30.6 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $297,820 - $361,238	-8,640 Reduced 15.2%	48,209 $2.13 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $862,229 - $919,223	-26,144 Reduced 31.5%	56,849 $2.06 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $1.05 Million - $1.22 Million	32,973 Added 65.92%	82,993 $2.95 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $63,027 - $66,874	1,895 Added 3.94%	50,020 $1.81 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.49 Million - $1.64 Million	48,125	48,125 $1.73 Million

Others Institutions Holding PFE

# of Institutions

3,354

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Pfizer Inc Transaction History